Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Allogeneic human dendritic cells derived from a CD34+ progenitor cell line

EU orphan designation number: EU/3/12/969   
Active ingredient: Allogeneic human dendritic cells derived from a CD34+ progenitor cell line
Indication: Treatment of acute myeloid leukaemia
Sponsor: DCPrime BV
Galileiweg 8, 2333 BD Leiden, Nederland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
25/05/2012 Centralised Orphan - Designation EMA/OD/101/11 (2012)3480 of 22/05/2012
27/03/2014 Centralised Orphan - Change of address